Chemical Component Summary

Nametert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate
Identifierstert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate
FormulaC16 H21 N3 O3 S
Molecular Weight335.421
TypeNON-POLYMER
Isomeric SMILESCC(C)(C)OC(=O)N1CCC(CC1)c2nc(no2)c3cccs3
InChIInChI=1S/C16H21N3O3S/c1-16(2,3)21-15(20)19-8-6-11(7-9-19)14-17-13(18-22-14)12-5-4-10-23-12/h4-5,10-11H,6-9H2,1-3H3
InChIKeyMETBQPRXNZHZMB-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count44
Chiral Atom Count0
Bond Count46
Aromatic Bond Count11

Drug Info: DrugBank

DrugBank IDDB08469 
Nametert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate
Groups experimental
Synonymstert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate

Drug Targets

NameTarget SequencePharmacological ActionActions
HTH-type transcriptional regulator EthRMTTSAASQASLPRGRRTARPSGDDRELAILATAENLLEDRPLADISVDDL...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 18690028